S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Fraud overwhelms pandemic-related unemployment programs
pixel
Texas power company seeks bankruptcy protection after storm
Stocks climb more than 2% as investors get back to buying
AG sues Texas utility over customers' sky-high energy bills
pixel
Want To Learn How To Code for Free? Discover 12 Low-Cost and Free Courses
Countries call on drug companies to share vaccine know-how
Stocks rally on Wall Street, S&P 500 has best day since June
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Fraud overwhelms pandemic-related unemployment programs
pixel
Texas power company seeks bankruptcy protection after storm
Stocks climb more than 2% as investors get back to buying
AG sues Texas utility over customers' sky-high energy bills
pixel
Want To Learn How To Code for Free? Discover 12 Low-Cost and Free Courses
Countries call on drug companies to share vaccine know-how
Stocks rally on Wall Street, S&P 500 has best day since June
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Fraud overwhelms pandemic-related unemployment programs
pixel
Texas power company seeks bankruptcy protection after storm
Stocks climb more than 2% as investors get back to buying
AG sues Texas utility over customers' sky-high energy bills
pixel
Want To Learn How To Code for Free? Discover 12 Low-Cost and Free Courses
Countries call on drug companies to share vaccine know-how
Stocks rally on Wall Street, S&P 500 has best day since June
pixel
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.59
Fraud overwhelms pandemic-related unemployment programs
pixel
Texas power company seeks bankruptcy protection after storm
Stocks climb more than 2% as investors get back to buying
AG sues Texas utility over customers' sky-high energy bills
pixel
Want To Learn How To Code for Free? Discover 12 Low-Cost and Free Courses
Countries call on drug companies to share vaccine know-how
Stocks rally on Wall Street, S&P 500 has best day since June
pixel
Log in
NASDAQ:SAGE

Sage Therapeutics Earnings Date, Estimates & History

Most-Downgraded Stocks  
$87.28
+2.28 (+2.68 %)
(As of 03/1/2021 12:00 AM ET)
Add
Compare
Today's Range
$83.95
Now: $87.28▼
$88.51
50-Day Range
$78.47
MA: $85.27▼
$96.76
52-Week Range
$25.01
Now: $87.28▼
$98.39
Volume404,190 shs
Average Volume499,652 shs
Market Capitalization$5.10 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.23

Earnings

Sage Therapeutics (NASDAQ:SAGE) Earnings Information

Sage Therapeutics last issued its earnings results on February 24th, 2021. The biopharmaceutical company reported $18.19 EPS for the quarter, beating analysts' consensus estimates of ($2.17) by $20.36. Sage Therapeutics has generated ($13.38) earnings per share over the last year. Sage Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 6th, 2021 based off prior year's report dates.

Sage Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Sage Therapeutics (NASDAQ:SAGE) Earnings Estimates

2021 EPS Consensus Estimate: ($8.90)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20217($3.41)($1.64)($2.13)
Q2 20217($3.64)($1.72)($2.18)
Q3 20217($4.15)($1.78)($2.30)
Q4 20217($3.70)($1.83)($2.29)

Sage Therapeutics (NASDAQ SAGE) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/6/2021
(Estimated)		       
2/24/202112/31/2020($2.17)$18.19($23.13)Transcript
11/5/20209/30/2020($2.30)($2.03)($2.03)$1.85 million$1.64 millionTranscript
8/10/20206/30/2020($2.67)($2.63)($1.53)$0.88 million$1.09 millionTranscript
5/7/2020Q1($3.17)($2.44)($2.44)$2.81 million$2.29 millionTranscript
2/27/2020Q4($3.62)($3.25)($3.25)$3.76 million$1.96 millionTranscript
11/12/2019Q3($3.41)($3.48)($3.48)$2.52 million$3.57 millionTranscript
8/6/2019Q2 2019($3.32)($3.28)($3.28)$0.27 million$0.87 millionListen
5/2/20193/31/2019($3.17)($3.37)($3.37)$0.47 millionN/A
2/19/201912/31/2018($2.89)($3.38)($3.38)$0.27 millionListen
11/6/2018Q3($2.41)($2.63)($2.63)N/A
8/7/2018Q2 2018($1.84)($0.36)($0.36)$90.00 millionN/A
5/3/2018Q1 2018($1.84)($1.68)($1.68)N/A
2/22/2018Q4 2017($1.9810)($1.75)($1.75)N/A
11/2/2017Q3 2017($1.9830)($1.97)($1.97)N/A
8/3/2017Q2 2017($1.63)($1.88)($1.88)Listen
5/9/2017Q1 2017($1.6080)($1.52)($1.52)Listen
2/23/2017Q4 2016($1.14)($1.50)($1.50)N/A
11/3/2016Q3 2016($1.16)($1.15)($1.15)N/A
8/9/2016Q2 2016($1.04)($1.08)($1.08)N/A
5/5/2016Q1 2016($0.97)($0.97)($0.97)Listen
2/24/2016Q4 2015($0.91)($0.99)($0.99)Listen
11/5/2015Q3 2015($0.85)($0.84)($0.84)N/A
8/12/2015Q2 2015($0.71)($0.90)($0.90)N/A
5/14/2015Q1 2015($0.56)($0.66)($0.66)N/A
2/27/2015Q414($0.44)($1.57)N/A
11/11/2014Q3 2014($0.47)($0.50)($0.50)N/A
8/14/2014Q2 2014($0.83)($4.57)($4.57)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/2/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.